Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2014 April;105(2) > Minerva Medica 2014 April;105(2):129-36

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

  PANCREATOLOGY


Minerva Medica 2014 April;105(2):129-36

language: English

Prevention of post-ERCP pancreatitis

Baron T. H. 1, Irani S. 2

1 Division of Gastroenterology and Hepatology University of North Carolina, Chapel Hill, NC, USA;
2 Department of Gastroenterology Virginia Mason Medical Center, Seattle, WA, USA


PDF  


Over the last 10-15 years there have been refinements in the understanding of risk factors for development of acute post-ERCP pancreatitis (PEP). These risk factors can be divided into patient risks and procedural risks. The most basic way to prevent PEP is avoidance of purely diagnostic ERCP and low-probability ERCP for bile duct stones by use of non-invasive or less-invasive imaging procedures. Improvement in cannulation techniques has led to a reduction in PEP. Placement of prophylactic pancreatic stents and, more recently, use of rectally administered non-steroidal anti-inflammatory agents (NSAIDs) has further reduced the risk of PEP in high-risk patients and/or following high-risk procedures. In this review the methods for prevention of PEP will be discussed.

top of page

Publication History

Cite this article as

Corresponding author e-mail

todd_baron@med.unc.edu